Patents for C12R 1 - Micro-organisms (92,025) |
---|
02/27/2002 | CN1079835C Process for recovering polyhydroxyalkanoates using air classification |
02/27/2002 | CN1079834C Mucicipal solid waste processing facility and commerical lactic acid production process |
02/27/2002 | CN1079832C Polypeptide for expressing virus of pig reproduction and respiration syndrome in same cell |
02/27/2002 | CN1079830C Methods and materials for treatment of individuals infected with intracellular infections agents |
02/26/2002 | US6350857 Fifty-four homologue (ffh) from streptococcus pneumoniae |
02/26/2002 | US6350856 Cytokine suppressive anti-inflammatory drug binding protein |
02/26/2002 | US6350855 Human interleukin-11 receptor |
02/26/2002 | US6350612 Cloned and sequenced eco ri fragment of bordetella pertussis chromosomal dna with 4696 base pairs containing genes which code for five subunits of pertussis toxin or fragments thereof containing at least one gene which codes for subunit of toxin |
02/26/2002 | US6350605 Cultures of algae and manganese oxidizing bacteria; removing and recycling manganese from water |
02/26/2002 | US6350598 MurD |
02/26/2002 | US6350596 Method for producing L-phenylalanine |
02/26/2002 | US6350593 Receptors for fibroblast growth factors |
02/26/2002 | US6350587 Bacillus strain and antibiotic screening method |
02/26/2002 | US6350575 Helper viruses for the preparation of recombinant viral vectors |
02/26/2002 | CA2083177C Alveolar surfactant proteins |
02/26/2002 | CA2078875C High level expression of basic fibroblast growth factor having a homogeneous n-terminus |
02/26/2002 | CA1341343C Immunoassay and biological constructs for use therein |
02/26/2002 | CA1341342C Aspergillus niger transformation system |
02/23/2002 | CA2355298A1 Microbial production of l-ascorbic acid and d-erythorbic acid |
02/21/2002 | WO2002014595A1 A method for treating proteinaceous fibres |
02/21/2002 | WO2002014528A1 Stereoselective reduction of substituted oxo-butanes |
02/21/2002 | WO2002014518A1 Method of modifying microorganism-origin transglutaminase |
02/21/2002 | WO2002014488A1 Novel protein derived from agkistrodon saxatilis emelianov and process for preparing the same |
02/21/2002 | WO2002014484A1 A tyrosinase enzyme |
02/21/2002 | WO2002014478A2 IMMUNOGENIC HBc CHIMER PARTICLES HAVING ENHANCED STABILITY |
02/21/2002 | WO2002013839A1 Animal papilla disinfectants and method of improving microbial environment |
02/21/2002 | WO2002013602A1 Transgenic non-human mammal and method of constructing the same, animal disease model and method of clarifying gene function |
02/21/2002 | WO2001081608A3 Viral vectors for use in monitoring hiv drug resistance |
02/21/2002 | WO2001053532A3 Barcoded synthetic lethal screening to identify drug targets |
02/21/2002 | WO2001027306A3 Biosynthesis of polyketide synthase substrates |
02/21/2002 | WO2001023605A3 Method and nucleic acids for determining the presence of micro-organisms specific to the brewing process |
02/21/2002 | WO2000069269A9 Strains of bacteriophage useful for rescuing patients infected with vancomycin-resistant enterococcus faecium |
02/21/2002 | US20020022718 Genes identified as required for proliferation of E. coli |
02/21/2002 | US20020022717 Using monoclonal antibodies |
02/21/2002 | US20020022595 Treating inflammation resulting from a response of the non-specific defense system in a mammal by administering an antiinflammatory agent and the uncontaminated Mac-1 alpha subunit |
02/21/2002 | US20020022268 Culturing primate progenitor tissues; obtain tissues, harvest nutrients from culture, monitor tissue propagation |
02/21/2002 | US20020022253 Polyhydroxyalkanoate, method for production thereof and microorganisms for use in the same |
02/21/2002 | US20020022238 Genetically engineered microorganism for use as tools in the generation of heterologous binding proteins |
02/21/2002 | CA2420037A1 Immunogenic hbc chimer particles having enhanced stability |
02/21/2002 | CA2418240A1 A disinfectant for teats of animals, and a method for improving microorganism-enviroment harmful for animals |
02/21/2002 | CA2417086A1 Stereoselective reduction of substituted oxo-butanes |
02/20/2002 | EP1180523A1 Plant activator, process for producing the same, activation method, activity promoter and method for applying the promoter |
02/20/2002 | EP1180161A2 A process for the preparation of derivatives of ruscus aculeatus steroid glycosides by enzymatic hydrolysis |
02/20/2002 | EP1180158A1 Compositions and methods for production of recombinant virus using a carrier vector derived from a nonmammalian virus |
02/20/2002 | EP1180155A1 Vector for integration of heterologous sequences into poxviral genomes |
02/20/2002 | EP1180154A1 PROMOTER OF THIOREDOXINE TaTrxh2 IN WHEAT |
02/20/2002 | EP1180153A1 Phage-dependent super-production of biologically active proteins and peptides |
02/20/2002 | EP1180148A1 A VARIANT OF C6 BETA-CHEMOKINE LEUKOTACTIN-1(shLkn-1) WITH ENHANCED BIOLOGICAL ACTIVITY |
02/20/2002 | EP1180141A2 The p2x 3 receptor, methods of altering p2x 3receptor activity and uses thereof |
02/20/2002 | EP1180139A1 Trehalose synthase protein, gene, plasmids, microorganisms, and a process for producing trehalose |
02/20/2002 | EP1180120A2 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant |
02/20/2002 | EP1180119A2 RECOMBINANT $i(HAEMOPHILUS INFLUENZAE) ADHESIN PROTEINS |
02/20/2002 | EP0874992B1 Compounds and methods for the detection and prevention of t. cruzi infection |
02/20/2002 | EP0667904B1 Suppressor and progenitor cells |
02/19/2002 | US6348643 For transgenic plants with improved herbicide resistance especially for imidazolinone herbicides |
02/19/2002 | US6348582 Prokaryotic polynucleotides polypeptides and their uses |
02/19/2002 | US6348578 Apt |
02/19/2002 | US6348574 An antibody; diagnosis and therapy for tumors, strokes, vasoconstriction, bronchial asthma, and atherosclerosis |
02/19/2002 | US6348349 A rodent embryonic stem cell transformed with yeast artifical chromosomes, with introducing yeast dna; for efficient transformations |
02/19/2002 | US6348337 Process for the preparation of C-4 deacetyltaxanes |
02/19/2002 | US6348335 Metabolism active materials, heating and cooling yeasts then isolation |
02/19/2002 | US6348334 DNA encoding Fas ligand |
02/19/2002 | US6348327 Non-endocrine animal host cells capable of expressing variant proinsulin and processing the same to form active, mature insulin and methods of culturing such cells |
02/19/2002 | US6348326 Process for producing L-ribose |
02/19/2002 | CA2141060C Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods |
02/19/2002 | CA2048813C Food products containing degraded cellulose derivatives |
02/19/2002 | CA2032963C Process for producing 7-aminocephem compound or salts thereof |
02/19/2002 | CA2023246C Mutants of human interleukin-3 |
02/14/2002 | WO2002012536A1 Modified yeasts and uses thereof, in particular for producing steroid derivatives |
02/14/2002 | WO2002012530A2 3-hydroxycarboxylic acid production and use in branched polymers |
02/14/2002 | WO2002012485A1 Promoter, vector and recombinant microorganism having the same and process for producing protein |
02/14/2002 | WO2002012466A2 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same |
02/14/2002 | WO2002012462A2 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same |
02/14/2002 | WO2002012446A1 Transformation and modification of natural drug by intestinal probiotic fermentative culture |
02/14/2002 | WO2002012307A1 Urocortin proteins and uses thereof |
02/14/2002 | WO2002012272A2 Therapeutic anti-melanoma compounds |
02/14/2002 | WO2002011563A1 Food supplement |
02/14/2002 | WO2001059163A3 Method for detecting and quantifying adenovirus |
02/14/2002 | WO2001057210A3 Use of dendroaspin as a vehicle for non-dendroaspin domains |
02/14/2002 | WO2001044489A3 Galactomannan oligosaccharides and methods for the production and use thereof |
02/14/2002 | WO2001038362A3 Production of vaccines |
02/14/2002 | US20020019515 Novel spoIIIE |
02/14/2002 | US20020019050 Hybrid microorganism for use in gene therapy |
02/14/2002 | US20020019046 Generating preferential aggregations; prepare suspension of stem cells, plate on solid surface, harvest aggregations |
02/14/2002 | US20020019042 Storing microorganisms with preferential enzymatic activity; obtain microorganisms, incubate in storage solution, monitor microorganisms for preferential enzymatic activity |
02/14/2002 | US20020019041 Storing adenoviruses; preparing liquid composition, maintain liquid at freezing, monitor adenovirues for activity |
02/14/2002 | US20020019034 Process for preparation of optically active 1,2-diols by cultivating microorganisms |
02/14/2002 | US20020019031 Genetically engineered cells for use in the generation of heterologous polypeptides |
02/14/2002 | US20020018990 Reagents and methods useful for detecting diseases of the breast |
02/14/2002 | US20020018782 Binding to antibodies; prophylaxis, therapy of infections |
02/14/2002 | US20020018775 Complexing; separation; gene therapy |
02/14/2002 | US20020018750 Anticancer agents |
02/14/2002 | DE10037270A1 Silicatein-vermittelte Synthese von amorphen Silikaten und Siloxanen und ihre Verwendung Silicatein-mediated synthesis of amorphous silicates and siloxanes and their use |
02/14/2002 | CA2419066A1 Food supplement |
02/14/2002 | CA2418370A1 Modified yeasts and uses thereof, in particular for producing steroid derivatives |
02/14/2002 | CA2418144A1 Urocortin proteins and uses thereof |
02/14/2002 | CA2416890A1 Therapeutic anti-melanoma compounds |
02/14/2002 | CA2416434A1 3-hydroxycarboxylic acid production and use in branched polymers |
02/13/2002 | EP1179597A1 Method for producing threonine and isoleucine |
02/13/2002 | EP1179593A1 Process for producing recombinant insulin from novel fused protein |